Class II · Moderate risk
Cold Relief
cGMP deviations
FDA Drug Recalls
1,206 recalls · Class II, newest first
Class II · Moderate risk
Backache & Muscle Relief
cGMP deviations
Class II · Moderate risk
Multi-Symptom Cramp Relief
cGMP deviations
Class II · Moderate risk
Cold Relief Severe Pain/Cough
cGMP deviations
Class II · Moderate risk
Lite Remfresh Advanced Ion-Powered Melatonin
cGMP deviations
Class II · Moderate risk
Multi Symptom Cold Relief
cGMP deviations
Class II · Moderate risk
Cetafen Non-aspirin pain reliever
cGMP deviations
Class II · Moderate risk
Back Pain-Off
cGMP deviations
Class II · Moderate risk
MidNite Sleep Health
cGMP deviations
Class II · Moderate risk
Class II · Moderate risk
Ephedrine Plus
cGMP deviations
Class II · Moderate risk
DBI 357 Super Magnum Quick Energy Stimulant
cGMP deviations
Class II · Moderate risk
Cystex Urinary Pan Relief
cGMP deviations
Class II · Moderate risk
Legatrin PM Pain Reliever/Sleep Aid
cGMP deviations
Class II · Moderate risk
Extra Strength
cGMP deviations
Class II · Moderate risk
Chloresin
cGMP deviations
Class II · Moderate risk
Maximum Strength Non Aspirin Pain Reliever/Fever Reducer
cGMP deviations
Class II · Moderate risk
AERO TAB Cold Relief
cGMP deviations
Class II · Moderate risk
Class II · Moderate risk
Nasal & Sinus Decongestant
cGMP deviations
Class II · Moderate risk
Proctofoam HC
cGMP deficiencies
Class II · Moderate risk
Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 mg/10 mg
Failed Dissolution Specification: Dissolution results are below specification limits for the active ingredient
Class II · Moderate risk
Moxifloxacin Ophthalmic Solution
Failed Impurities/Degradation Specifications
Class II · Moderate risk
Lexette (halobetasol propionate)
CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.
Class II · Moderate risk
Metoprolol Succinate Extended-Release Tablets
Failed Dissolution Specifications.